A common point of opposition to offering buprenorphine in correctional settings is the perceived risk of diversion, disciplinary issues, or safety concerns created by allowing access to buprenorphine.
Vital Strategies supported technical assistance to six county jails in Pennsylvania that had been funded by the Commonwealth to expand access to buprenorphine to incarcerated persons.
This snapshot looks at the reported incidence of diversion, assault, and conduct citations at the six jails in Pennsylvania that together provided buprenorphine to more than 1,000 individuals over an 18 month period through this state-funded grant program.
Recent Abstracts
Foundations & Futures: Reimagining Public Health in the Artificial Intelligence Era
Strengthening Health Systems to Address Air Pollution in Ethiopia
Policy Brief: Childhood Blood Lead Surveillance in Indonesia – Findings and Policy Recommendations
Impact of Blue Lanes on Road Safety: Crashes, Speed and Motorcyclists’ Perceptions in…
Impacto da Faixa Azul na Segurança Viária: Sinistros, velocidade e percepções de motociclistas…
Culture is Medicine- a Model of Indigenous Harm Reduction in Practice
Trouble Brewing – The Case for Alcohol Policy (Second Edition)
Lessons from Vietnam’s Campaign for a Tax on Sugar-Sweetened Beverages
Principles of Alcohol Taxation
Clean Air in Jakarta: Gaps and Possibilities Toward Low Emission Practices